Genmab A/s Stock Performance
as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
$27.84$28.27
0.89%
Downside
0.64%
Upside
52 Week's Low
52 Week's High
$17.24$28.7538.64%
Downside
2.33%
Upside
Genmab A/s share price movements today
- Previous Close
- $28.24
- Open
- $27.86
- Volume
- 1.3M
- Day's Low - High
- $27.84 - $28.27
- 52 Week Low - High
- $17.24 - $28.75
Genmab A/s Historical Returns
- 1 Month Return
- + 21.15 %
- 3 Month Return
- + 28.19 %
- 1 Year Return
- + 6.85 %
- 3 Year Return
- -22.55 %
- 5 Year Return
- -24.83 %
Genmab A/s Stock Fundamentals & Key Indicators
Check Genmab A/s market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$17.4B
EPS (TTM)
1.6833
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.73%
PE Ratio (TTM)
14.48
Industry PE ratio
16.65525641025641
P/B Ratio
14.4821
PEG Ratio
1.2199
EBITDA
1.3B
Revenue (TTM)
3.6B
Profit Margin
37.59%
Return On Equity TTM
28.12%
Genmab A/s Stock Valuation
Track how Genmab A/s P/E has moved over time to understand its valuation trends.
Genmab A/s in the last 5 years
Lowest (3.17x)
September 30, 2020
Today (14.48x)
September 17, 2025
Industry (16.66x)
September 17, 2025
Highest (64.13x)
September 30, 2021
Today’s Price to Earnings Ratio: 14.48x
Genmab A/s vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Genmab A/s with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $17.4B | -24.83% | 14.48 | 37.59% | |
| BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
| NA | $39.0B | NA | NA | -3.89% | |
| BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
| BUY | $59.6B | 1.78% | 14.1 | 31.37% |
Stock Returns calculator for Genmab A/s Stock including INR - Dollar returns
The Genmab A/s stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Genmab A/s investment value today
Current value as on today
₹1,10,879
Returns
₹10,879
(+10.88%)
Returns from Genmab A/s Stock
₹6,281 (+6.28%)
Dollar Returns*
₹4,598 (+4.6%)
Analyst Recommendation on Genmab A/s Stock
Based on 31 analysts
61.29%
Buy
29.03%
Hold
9.68%
Sell
Based on 31 analysts, 61.29% of analysts recommend a 'BUY' rating for Genmab A/s. Average target price of $30.41
Genmab A/s Share Price Target
Get share price movements and forecasts by analysts on Genmab A/s.
What analysts predicted
7.63%UPSIDE
Target Price
$30.41
Current Price
$28.09
Analyzed by
31 Analysts
Target
$30.41
Genmab A/s target price $30.41, a slight upside of 7.63% compared to current price of $28.09. According to 31 analysts rating.
Genmab A/s Stock's Interest Amongst Investors
Search interest for Genmab A/s Stock has increased by 35% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:35% versus previous 30 day period
Genmab A/s Quarterly Profit & Loss
All numbers in Millions USD
Genmab A/s Annual Profit & Loss
All numbers in Millions USD
Genmab A/s Quarterly Cash Flow
All numbers in Millions USD
Genmab A/s Annual Cash Flow
All numbers in Millions USD
Global Institutional Holdings in Genmab A/s
Insights on Genmab A/s
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 195.0M → 2.12B (in $), with an average increase of 90.8% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 4.93B → 5.86B (in $), with an average increase of 15.9% per quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, GMAB stock has moved up by 21.1%
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 139.0%
- NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 61.3%
About Genmab A/s
| Organisation | Genmab A/s |
| Headquarters | Carl Jacobsens Vej 30, Copenhagen, Denmark, 2500 |
| Industry | Health Technology |
| CEO | Dr. Jan G.J. van de Winkel Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Genmab A/s
Name | Title |
|---|---|
Dr. Jan G.J. van de Winkel Ph.D. | Co-Founder, President & CEO |
Mr. Rayne Waller | Executive VP & Chief Technical Operations Officer |
Mr. Christopher Cozic | Executive VP & Chief People Officer |
Dr. Martine J. van Vugt Ph.D. | Executive VP & Chief Strategy Officer |
Mr. Takahiro Hamatani | Senior Director of Finance Japan & Non-Independent Director |
Mr. Anthony Pagano CPA | Executive VP & CFO |
Mr. Martin Schultz | Senior Director of Clinical Operations & Non-Independent Director |
Dr. Judith V. Klimovsky M.D. | Executive VP & Chief Development Officer |
Dr. Tahamtan Ahmadi M.D., Ph.D. | Executive VP, Chief Medical Officer & Head of Experimental Medicines |
Dr. Mijke Zachariasse Ph.D. | Senior Director, Head of Antibody Research Materials & Non-Independent Director |
FAQs
What is Genmab A/s share price today?
Genmab A/s share price today is $28.09 as on at the close of the market. Genmab A/s share today touched a day high of $28.27 and a low of $27.84.
What is the 52 week high and 52 week low for Genmab A/s share?
Genmab A/s share touched a 52 week high of $28.75 on and a 52 week low of $17.24 on . Genmab A/s stock price today i.e. is closed at $28.09,which is 2.28% down from its 52 week high and 62.98% up from its 52 week low.
What is Genmab A/s's market capitalisation today?
Genmab A/s market capitalisation is $0.02T as on .
How to invest in Genmab A/s Stock (GMAB) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Genmab A/s on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Genmab A/s Shares that will get you 0.0534 shares as per Genmab A/s share price of $28.09 per share as on September 18, 2025 at 1:29 am IST.
What is the minimum amount required to buy Genmab A/s Stock (GMAB) from India?
Indian investors can start investing in Genmab A/s (GMAB) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Genmab A/s stock (as per the Rupee-Dollar exchange rate as on ).
Based on Genmab A/s share’s latest price of $28.09 as on September 18, 2025 at 1:29 am IST, you will get 0.3560 shares of Genmab A/s. Learn more about
fractional shares .
What are the returns that Genmab A/s has given to Indian investors in the last 5 years?
Genmab A/s stock has given -24.83% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?